-
-
-
-
-
-
-
AB Announces June 30, 2026 Assets Under Management
-
-
-
-
-
-
-
AB Science is invited to present at the 2026 ENCALS annual meeting the survival data from masitinib clinical program in ALS
-
-
-
-
-
-
-
AB Science announces a final agreement on the renegotiation of the repayment terms of its loans with all of its financial creditors
-
-
-
-
-
-
-
AB Announces January 31, 2026 Assets Under Management
-
-
-
-
-
-
-
AB Science reports fourth patient response in AB8939 venetoclax trial
-
-
-
-
-
-
-
AB Announces November 30, 2025 Assets Under Management
-
-
-
-
-
-
-
AB Science reports initial results from cancer drug trial
-
1,233,803 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


